TABLE OF CONTENTS


As filed with the Securities and Exchange Commission on April 24, 2017

May 30, 2019

Registration No. 333-217382333-



UNITED STATES


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
Amendment No. 1
to

FORM S-3

REGISTRATION STATEMENT


UNDER THE SECURITIES ACT OF 1933

COLUMBUS McKINNON CORPORATION


(Exact name of registrant as specified in its charter)

New York
16-0547600
New York
(State or other jurisdiction of

incorporation or organization)
16-0547600
(I.R.S. Employer

Identification No.)

205 Crosspoint Parkway


Getzville, New York 14068

(716) 689-5400

(Address, including zip code, and telephone number, including area code, of registrant’s
principal executive offices)

Alan S. Korman


Vice President, General Counsel and Corporate Secretary

Columbus McKinnon Corporation

205 Crosspoint Parkway

Getzville, New York 14068

(716) 689-5400

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Please send copies of all communications to:

Jamie Knox,

Robert J. Olivieri, Esq.

Christopher C. Paci, Esq.
DLA Piper
Hodgson Russ LLP (US)
1251 Avenue of the Americas

The Guaranty Building
140 Pearl Street, Suite 100
Buffalo, New York New York 10020
(212) 335-4500
14202-4040





(716) 856-4000

Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this registration statement.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:  o

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: x


If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  o

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.  o

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer o
Accelerated filer  x
Non-accelerated filer   o
Smaller reporting company   o
Non-accelerated filer  o
Smaller reporting company  o
(Do not check if a smaller reporting company)
Emerging growth company   o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.






CALCULATION OF REGISTRATION FEE

Title of Each Class of
Securities to be Registered(1)
Amount to be
Registered(1)
Proposed Maximum
Aggregate Price
Per Unit(1)(2)
Proposed Maximum
Aggregate Offering
Price(1)(2)
Amount of
Registration Fee(3)
Common Stock, par value $.01
 
 
 
 
 
 
 
 
 
 
 
 
Preferred Stock, par value $1.00
 
 
 
 
 
 
 
 
 
 
 
 
Debt Securities
 
 
 
 
 
 
 
 
 
 
 
 
Warrants
 
 
 
 
 
 
 
 
 
 
 
 
Rights(4)
 
 
 
 
 
 
 
 
 
 
 
 
Stock Purchase Contracts
 
 
 
 
 
 
 
 
 
 
 
 
Units of the Securities listed above
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees of Debt Securities by the Subsidiary Guarantors(5)(6)
 
 
 
 
 
 
 
 
 
 
 
 
Total Registration Fee
 
 
 
 
 
 
$
300,000,000
 
$
36,360
 

Title of Each Class of
Securities to be Registered
Amount to be
Registered
Proposed Maximum
Aggregate Price Per
Unit(1)
Proposed Maximum
Aggregate Offering
Price(1)
Amount of
Registration
Fee(2)
Common Stock, par value $.01(3)
2,273,000$24.785$56,336,305$6,530

(Footnote reference on next page)


TABLE OF CONTENTS

(Continued from previousn page)

(1)An indeterminate number of or aggregate principal amount of shares of common stock, preferred stock, warrants, rights, stock purchase contracts, debt securities and units consisting of such securities of the registrant, as shall have an aggregate initial offering price not to exceed $300,000,000 as may from time to time be issued at an indeterminate price. This registration statement also relates to an indeterminate number of shares of the registrant’s common stock that may be issued upon stock splits, stock dividends or similar transactions in accordance with Rule 416 of the Securities Act of 1933, as amended (the “Securities Act”). If any debt securities are issued at an original issue discount, then the debt securities registered shall include such additional debt securities as may be necessary such that the aggregate initial public offering price of all securities issued pursuant to this registration statement will equal $300,000,000. The securities registered also include such indeterminate amounts and numbers of common stock, preferred stock, warrants, rights, stock purchase contracts, debt securities and units as may be issued upon conversion of or exchange for debt securities that provide for such conversion or exchange.
(2)Not specified as to each class of securities pursuant to General Instruction II.D to Form S-3 under the Securities Act.
(1)(3)Estimated solely for the purpose of computingcalculating the amountregistration fee in accordance with Rule 457(o) under the based on the maximum offering price of all securities listed. Pursuant to Rule 457(p) under the Securities Act, Columbus McKinnon Corporation is offsetting $25,175 of the registration fee pursuantpreviously paid with respect to its registration statement on Form S-3 (File Number 333-212862 ) filed with the Securities and Exchange Commission on August 3, 2016 against the filing fee of $36,360 due under this registration statement. The balance of the registration fee in the amount of $11,185 is being paid with this filing.
(4)Rights evidencing the right to purchase Columbus McKinnon Corporation common stock, preferred stock, warrants, stock purchase contracts, units or debt securities.
(5)No separate consideration will be received for the guarantees by the Subsidiary Guarantors of the debt securities of Columbus McKinnon Corporation. Pursuant to Rule 457(c) under457(n) of the Securities Act, of 1933, as amended, based on an average ofno registration fee is required with respect to the high and low reported sales prices of the Registrant’s common stock, par value $0.01 per share, as reported on the NASDAQ Global Select Market on April 13, 2017, of $25.19 and $24.38.guarantees.
(6)
(2)Previously paid. No separate consideration is payable for the preferred share purchase rights associated with the common stock registered hereby. The registration fee for these securities is included in the registration fee for the common stock.term “Subsidiary Guarantors” refers to Magnetek, Inc., Unified Industries, Inc. and Yale Industrial Products, Inc.
(3)Includes the associated preferred share purchase rights.

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to Section 8(a), may determine.




TABLE OF CONTENTS

Table of Registrant Guarantors(1)

Name(1)
State or other jurisdiction
of incorporation or
organization
IRS Employer
Identification
Number
Magnetek, Inc.
Delaware
95-3917584
Unified Industries, Inc.
Michigan
38-1429336
Yale Industrial Products, Inc.
Delaware
71-0585582

(1)The Subsidiary Guarantors may guarantee the debt securities issued hereunder and are co-registrants under this registration statement
(2)The address, including zip code, and telephone number, including area code, of each of the Registrant Guarantors principal executive office is 205 Crosspoint Parkway, Getzville, New York 14068, (716) 689-5400..




TABLE OF CONTENTS

The information in this prospectus is not complete and may be changed. The selling shareholdersCompany may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

SUBJECT TO COMPLETION, DATED APRIL 24, 2017

MAY 30, 2019

PROSPECTUS

COLUMBUS McKINNON CORPORATION

COMMON STOCK

PREFERRED STOCK
2,273,000 SHARESWARRANTS
RIGHTS
STOCK PURCHASE CONTRACTS
DEBT SECURITIES
AND UNITS

And

GUARANTEES OF COMMON STOCK
This prospectus relates to the resaleDEBT SECURITIES OF COLUMBUS McKINNON
CORPORATION BY THE SUBSIDIARY GUARANTORS

We may sell from time to time by certain selling shareholdersin one or more offerings up to $300,000,000 in the aggregate of:

shares of our common stock;
shares of our preferred stock;
warrants;
rights to purchase our securities;
stock purchase contracts;
our secured or unsecured debt securities, in one or more series, which may be either senior, senior subordinated or subordinated debt securities; and
units consisting of any combination of the foregoing.

We may sell any combination of these securities, in one or more offerings, up to an aggregate offering price of 2,273,000 shares of common stock, par value $0.01 per share (the “common stock”), issued$300,000,000 on terms to the selling shareholders on January 30, 2017, pursuant to the Share Purchase Agreement (as defined herein), and the associated preferred share purchase rights. The selling shareholders may offer and sell shares of common stock in public or private transactions, or both. These sales may occur at fixed prices, at market prices prevailingbe determined at the time of sale, at prices related to prevailing market prices, or at negotiated prices.


the offering. The selling shareholdersdebt securities registered hereunder may sell all or a portionbe fully and unconditionally guaranteed by certain subsidiaries of Columbus McKinnon Corporation, which may include the Subsidiary Guarantors.

This prospectus describes some of the shares of common stock through underwriters, broker dealers or agents, whogeneral terms that may receive compensation in the form of discounts, concessions or commissions from the selling shareholders, the purchasers of the shares of common stock, or both. See “Plan of Distribution” for a more complete description of the ways in which the shares of common stock may be sold. The names of any underwriters, dealers or agents,apply to these securities. We will provide the specific terms of the plan of distribution, any over-allotment option and any applicable underwriting discounts and commissions will be set forthsuch offering in a supplementone or more supplements to this prospectus.


prospectus each time we sell securities hereunder. We are registering thecan only use this prospectus to offer and sale of the shares of common stock offeredsell our securities by this prospectus in order to satisfy certain registration rights we have granted to the selling shareholders. We have agreed to bear the expenses (other than underwriting discounts, selling commissions and stock transfer taxes) incurred in connection with the registration of the common stock that the selling shareholders are offering under this prospectus, but we will not receive any of the proceeds from the selling shareholders’ sale of shares of common stock. The registration of the shares of common stock covered by this prospectus does not necessarily mean that any of the shares will be offered or sold by the selling shareholders. The timing and amount of any sale is within the respective selling shareholders’ sole discretion, subject to certain restrictions. To the extent that any selling shareholder resells any shares covered by this prospectus, the selling shareholder may be required to provide you with this prospectus andalso including a prospectus supplement identifyingrelating to any such offer and containing specific information aboutsale.

We may sell the selling shareholdersecurities directly to you, through agents, underwriters and broker-dealers that we select. If we use agents, underwriters or broker-dealers to sell the terms of the shares being offered.

securities, we will name them and describe their compensation in a prospectus supplement. The net proceeds we expect to receive from any such sale will also be included in a prospectus supplement.

Our common stock is listed on the NASDAQ Global Select Market under the symbol “CMCO.” On April 21, 2017,May 17, 2019, the last reported sale price of our common stock on the NASDAQ Global Select Market was $25.44.



$35.19.

INVESTING IN OUR SECURITIES INVOLVES RISKS. YOU SHOULD CONSIDER CAREFULLY THE RISKS THAT WE HAVE DESCRIBED IN “RISK FACTORS” BEGINNING ON PAGE 12 BEFORE DECIDING WHETHER TO INVEST IN OUR COMMON STOCK.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus is .





TABLE OF CONTENTS


TABLE OF CONTENTS

Page
Page
SUMMARY
4
4
5
SELLING SHAREHOLDERS6
DESCRIPTION OF CAPITAL STOCK8
11
13
13
13
13

The distribution of this prospectus may be restricted by law in certain jurisdictions. You should inform yourself about and observe any of these restrictions. This prospectus does not constitute, and may not be used in connection with, an offer or solicitation by anyone in any jurisdiction in which the offer or solicitation is not authorized, or in which the person making the offer or solicitation is not qualified to do so, or to any person to whom it is unlawful to make the offer or solicitation.


We have not authorized anyone to provide you with any information or to make any representation that is different from, or in addition to, the information contained in this prospectus or any documents incorporated by reference in this prospectus. If anyone provides you with different, additional or inconsistent information, you should not rely on it. Unless the information specifically indicates that another date applies, you should not assume that the information contained in this prospectus, or the information contained in any document incorporated by reference in this prospectus, is accurate as of any date other than the date of each such document, as our business, financial condition, results of operations and prospects may have changed since that date.



i




i

TABLE OF CONTENTS

ABOUT THIS PROSPECTUS

This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the “SEC”) utilizing a “shelf” registration process or continuous offering process, which allows the selling shareholdersus to offer and sell any combination of the shares of our common stock coveredsecurities described in this prospectus in one or more offerings. The selling shareholdersUsing this prospectus, we may offer up to a total dollar amount of $300,000,000 of these securities.

The types of securities that we may offer and sell and seek offersfrom time to buy, shares of our time by this prospectus are:

common stock onlyof Columbus McKinnon Corporation;
preferred stock of Columbus McKinnon Corporation;
warrants entitling the holders to purchase common stock, preferred stock, units or debt securities of Columbus McKinnon Corporation;
rights to purchase Columbus McKinnon Corporation common stock, preferred stock, units or debt securities;
stock purchase contracts issued by Columbus McKinnon Corporation;
our secured or unsecured debt securities, in jurisdictions where such offersone or more series, which may be either senior, senior subordinated or subordinated debt securities; and sales are permitted.
units consisting of any of the above securities.

This prospectus provides you with a general description of the common stock the selling shareholderssecurities we may offer. Each time the selling shareholderswe offer to sell shares of our common stocksecurities pursuant to this registration statement and the prospectus contained herein, we will to the extent required by law, provide a prospectus supplement that will contain specific information about the terms of that offering. AnyThat prospectus supplement may include additional risk factors about us and the terms of that particular offering. Prospectus supplements may also add to, update or change the information contained in this prospectus. To the extent that any statement that we make in anya prospectus supplement or any related free writing prospectus is inconsistent with statements made in this prospectus, the statements made in this prospectus will be deemed modified or superseded by those made in such prospectus supplement or such related free writing prospectus.supplement. In addition, as we describe in the section entitled “Information Incorporated by Reference,” we have filed and plan to continue to file other documents with the SEC that contain information about us and the business conducted by us and our subsidiaries. Before you decide whether to invest in any of these securities, you should read this prospectus, the prospectus supplement that further describes the offering of these securities and the information we file with the SEC.


Neither we nor THIS PROSPECTUS MAY NOT BE USED TO CONSUMMATE A SALE OF SECURITIES UNLESS IT IS ACCOMPANIED BY A PROSPECTUS SUPPLEMENT.

Unless the selling shareholders have authorized any dealer, agent or other person to give any information or to make any representation other than those contained in or incorporated by reference into this prospectuscontext otherwise requires, the terms “Columbus McKinnon,” “the Company,” “the registrants,” “we,” “us” and any prospectus supplement or a related authorized free writing prospectus, and we and the selling shareholders take no responsibility for any other information that others may give you. This prospectus and any prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered shares of our common stock to which they relate, nor do this prospectus and any prospectus supplement constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained or incorporated by reference into this prospectus, any prospectus supplement or any related free writing prospectus is accurate as of any date other than the date of the document containing the information (as our business, financial condition, results of operations and prospects may have changed since that date), even though this prospectus, any prospectus supplement or any related free writing prospectus is delivered or shares of our common stock are sold on a later date.


As permitted by the rules and regulations of the SEC, the registration statement of which this prospectus forms a part includes additional information not contained in this prospectus. You may read the registration statement and the other documents we file with the SEC at the SEC’s website or at the SEC’s offices described below under the heading “Where You Can Find Additional Information.”



ii



SUMMARY

This summary highlights selected information from this prospectus and the documents incorporated herein by reference and does not contain all of the information that you need to consider in making your investment decision. You should carefully read the entire prospectus, including the risks of investing in our securities discussed under “Risk Factors” on page 3 of this prospectus, the information incorporated herein by reference, including our financial statements, and the exhibits to the registration statement of which this prospectus is a part. All references in this prospectus to “we,” “us,” “our,” “CMCO,” the “Company” and similar designations“our” refer to Columbus McKinnon Corporation and its consolidated subsidiaries, unless otherwise indicated or asand the context otherwise requires.term “Subsidiary Guarantors” refers to, collectively, Magnetek, Inc., Unified Industries, Inc. and Yale Industrial Products, Inc.


The Company

ii

TABLE OF CONTENTS

THE COMPANY

We are a leading globalworldwide designer, manufacturer and marketer of hoists, actuators, cranes, rigging tools, digital powermotion control products, technologies, systems and other material handling products serving a wide variety of commercial and industrial end-user markets. Our products are used toservices that efficiently and ergonomically move, lift, position and secure objectsmaterials. Key products include hoists, rigging tools, digital power control systems, and loads.actuators. We are focused on commercial and industrial applications that require safety and productivity in moving material provided by our superior design and engineering know-how. Our products are used for mission critical industrial applications where we have established trusted brands with significant customer retention. Our targeted market verticals include general industrial, construction and infrastructure, mining, oil & gas, energy, aerospace, transportation, automotive, heavy equipment manufacturing and entertainment.

In the U.S., we are the market leader infor hoists and material handling drivedigital power control systems, our principal line of products, as well as certain chain, forged attachment,fittings, and actuator products which we believe provides us with a strategic advantage in selling our other products. We have achieved this leadership position through strategic acquisitions, our extensive, diverse, and well-established distribution channels and our commitment to product innovation and quality. We have one ofbelieve the most comprehensive product offerings in the industry and we believe we have more overhead hoists in use in North America than allbreadth of our competitors combined.product offering and expansive distribution channels provide us a strategic advantage in our markets. Additionally, we believe we are the market leader offor manual hoist and actuator products in Europe, which providesEurope. Our market leadership and strong brands enable us further opportunity to sell more products than our other productscompetition through our existingextensive distribution channels in that region. the U.S. and Europe.

Our Blueprint for Growth Strategy is a three-phased strategy to increase the earnings power of the company and transform us into a growth-oriented industrial technology company. The goal of our strategy is to increase our earnings power and expand EBITDA margins, as well as improve our Return on Invested Capital.

We design, manufacture, and distribute a broad range of material handling products are sold globally and our brand names, including CM, Coffing, Chester, Duff-Norton, Pfaff, Shaw-Box, Yale, Telemotive, Electromotive Systems, OmniPulse, IMPULSE, Enrange, Mondel, M-FORCE, and Quattro are among the most recognized and well-respected in the marketplace


In September 2015, we significantly expanded our product offering with the acquisition of Magnetek, Inc. (“Magnetek”). The acquisition combines Magnetek’s technology with our broad line of lifting and positioning mechanical products to create a more comprehensive solution for customers. Magnetek's digital power control systems serve the needs of selected niches of traditional and emerging markets that are becoming increasingly dependent on “smart” power. Much of Magnetek's focus is on developing and introducing innovative electronic drive solutions that both enhance our customers' operational efficiency and save energy.

Our productsvarious applications. Products include a wide variety of electric, chain hoists, electric wire rope hoists, hand-operated hoists, winches,air-powered, lever, tools, air-poweredand hand hoists, hoist trolleys, overhead steel jibexplosion-protected hoists, winches, and gantry cranes,aluminum work stations; alloy and carbon steel chain, closed-diechain; forged attachments, such as hooks, shackles, textile slings, clamps, logging tools and load binders; industrial components, such as mechanical and electromechanical actuators and rotary unions; and below-the-hook special purpose lifters; tire shredders;power and light-rail systems.motion control systems, such as AC and DC drive systems, radio remote controls, push button pendant stations, brakes, and collision avoidance and power delivery subsystems. These products are typically manufactured for stock or assembled to order from standard components and are sold primarily through a variety of commercial distributors and to a lesser extent, directly to end-users. The diverse end-users of our products are in a variety of industries including:including manufacturing, power generation and distribution, utilities, wind power, warehouses, commercial construction, oil and gas exploration and refining, petrochemical, marine, ship building, transportation and heavy duty trucking, agriculture, logging and mining. We also serve a niche market for the entertainment industry including permanent and traveling concerts, live theater, and sporting venues.

For more information about our business, please refer to the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section of our Annual Reportannual report on Form 10-K for the fiscal year ended March 31, 2016 and our Quarterly Reports on Form 10-Q filed subsequent to such Annual Report on Form 10-K,2019 which areis incorporated by reference into this prospectus and any prospectus supplement hereto in their entirety, as the same may be amended, supplemented or superseded.






Our principal executive offices are located at 205 Crosspoint Parkway, Getzville, New York 14068. Our telephone number is (716) 689-5400. Our web site address is www.cmworks.com. The information on our website is not part of this prospectus.


Recent Developments

STAHL Acquisition

On January 31, 2017, we completed our acquisition of the STAHL CraneSystems business (“STAHL”), including all of the issued and outstanding capital stock of STAHL CraneSystems GmbH and nine STAHL affiliates, from Konecranes Plc. Combined with our Magnetek acquisition, we have measurably expanded our value proposition for our customers and have several opportunities to create a stronger combined business including expanding the scale and scope of the STAHL product platforms into emerging markets using our established global sales force, and the sharing of intelligence and engineering know-how among our businesses, including smart hoist technology. 

Debt Financing

On January 31, 2017, we closed on a new $545,000,000 debt facility (the “New Facilities”) with JPMorgan Chase Bank, N.A. (JP Morgan Chase Bank) previously reported on our Form 8-K filed on December 7, 2016 and updated in our Quarterly Report on Form 10-Q filed on January 26, 2017 and our Form 8-K filed on January 31, 2017. The New Facilities consist of a New Revolving Facility in the amount of $100,000,000 and a $445,000,000 First Lien Term Loan. Proceeds from the New Facilities were used to fund the STAHL acquisition, pay fees and expenses associated with the acquisition and refinance our existing term loan and credit facility.

Private Placement of Common Stock

On January 30, 2017, we completed the sale of 2,273,000 shares of our common stock, at a purchase price of $22.00 per share, for an aggregate purchase price of $50,006,000 (the “Equity Private Placement”) pursuant to a Share Purchase Agreement (the “Purchase Agreement”) with Adage Capital Partners, LP (“Adage”), CVI Investments Inc. (“CVI”), Nineteen77 Global Multi-Strategy Alpha (Levered) Master Limited (“Nineteen77”), O’Connor Global Multi-Strategy Alpha Master Limited (“O’Connor 1”), O’Connor Global Fundamental Market Neutral Long/Short Master Limited (“O’Connor 2”) and O’Connor Global Fundamental Market Neutral Long/Short (Levered) Master Limited (“O’Connor 3”, collectively Adage, CVI, Nineteen77, O’Connor 1, O’Connor 2 and O’Connor 3, the “Investors”). We used the net proceeds from the Equity Private Placement to fund in part the acquisition of STAHL, thereby reducing the amount of post-acquisition leverage and the cost of the debt.

In connection with the closing of the Equity Private Placement, we entered into a Registration Rights Agreement with the Investors (the “Registration Rights Agreement”) pursuant to which we granted the Investors the right to require the Company to file with the Securities and Exchange Commission a registration statement to register for resale the Investors’ shares of common stock (the “Registrable Securities”). The obligation to register the Registrable Securities continues until those securities have been sold by the holders of the registration rights or may be sold without limitation under Rule 144 under the Securities Act (“Rule 144”).

The foregoing description of the Purchase Agreement and the Registration Rights Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of such agreements, which are exhibits to the registration statement of which this prospectus is a part and are incorporated herein by reference.











The Offering

Securities offered by the selling shareholders2,273,000 shares of common stock
Use of ProceedsWe will not receive any proceeds from the sale of common stock by the selling shareholders.
NASDAQ Global Market symbol of common stockCMCO


1



TABLE OF CONTENTS

RISK FACTORS

An investment in our common stock involves risk. Prior to making a decision about investing in our securities, you should carefully consider those risk factors included in our most recent Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which are incorporated herein by reference, as well as those risk factors that may be included in any applicable prospectus supplement, together with all of the other information included in this prospectus, any prospectus supplement and the documents we incorporate by reference, in evaluating an investment in our common stock. If any of the risks discussed in the foregoing documents were to occur, our business, financial condition, results of operations and cash flows could be materially adversely affected. In addition to these risk factors, there may be additional risks and uncertainties of which management is not aware or focused on or that management deems immaterial. Any of these additional risk factors could have a material adverse effect on our business, results of operations, financial position or cash flows, which may result in the loss of all or part of your investment. For more information, please see the sections entitled “Cautionary Statement Regarding Forward-Looking Statements” and “Where You Can Find More Information.”


SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION

Statements made in this prospectus and the documents incorporated herein contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements that relate to future plans, events, liquidity, financial results or performance, including statements relating to future cash flows and liquidity and future cost alignment actions, as well as estimated unrecognized stock compensation expense, computation of the annual estimated effective tax rate at each interim period, projected capital expenditures, future contractual obligations, current business outlook, estimated charges related to the restructuring of global operations, future global economic conditions, future growth or market share gains, the ability to manage costs or invest in future initiatives, as well as future changes in foreign currency rates, are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would,” and similar expressions or expressions of the negative of these terms.

These statements involve known and unknown risks and are based upon current information and expectations. Actual results may differ materially from those anticipated if the information on which those estimates were based ultimately proves to be incorrect or as a result of certain risks and uncertainties that could cause our actual results to differ materially from the results expressed or implied by such statements, includingincreased exposure to markets and geographies in which STAHL is more concentrated than our existing business, such as the oil and gas industry and Europe, risks related to integration, such as disruptions in customer or vendor relationships or lost business, risks related to employee relations or risks related to diligence, such as contingent liabilities of STAHL that are unknown to the Company or turn out to be greater than the Company expects, risks related to doing business outside the United States, including varying legal protections, rights and obligations, risks related to global legal compliance, risks related to increased debt incurred to finance the acquisition, including the Company’s ability to service and repay such debt and the possibility that debt service could reduce the Company’s ability to take advantage of opportunities that would benefit the Company’s business, general economic and business conditions, conditions affecting the industries served by us and our subsidiaries, conditions affecting our customers and suppliers, competitor responses to our products and services, the overall market acceptance of such products and services, facility consolidations and other restructurings, foreign currency fluctuations, the integration of acquisitions and other factors disclosed in our periodic reports filed with the Securities and Exchange Commission (the “SEC”). Consequently such forward-looking statements should be regarded as our current plans, estimates and beliefs. We do not undertake and specifically decline any obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect any future events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.





USE OF PROCEEDS

We will not receive any proceeds from the sale by the selling shareholders of the shares of common stock registered pursuant to the registration statement of which this prospectus forms a part.



SELLING SHAREHOLDERS

On January 30, 2017, we issued 2,273,000 shares of common stock in a private offering to certain investors listed as selling shareholders in this prospectus. We are registering the securities offered by this prospectus on behalf of the selling shareholders.

The selling shareholders may from time to time offer and sell pursuant to this prospectus any or all of the shares of common stock listed below that have been issued to them.

The table below sets forth the name of the selling shareholders, the number of shares of common stock that are beneficially owned by each such selling shareholder and the number of shares of common stock that may be offered pursuant to this prospectus. The percentage of shares of common stock owned after the offering is based on 22,565,708 shares of common stock outstanding as of April 17, 2017.

Unless otherwise indicated in a prospectus supplement, we intend to use the footnotes tonet proceeds that we receive from the sale of any securities by us covered by this table, we believe that eachprospectus for general corporate purposes, which may include, among other things: reducing or refinancing indebtedness; making acquisitions of assets, businesses or securities; stock repurchases and capital expenditures; and for working capital. When specific securities are offered, the prospectus supplement relating thereto will set forth our intended use of the selling shareholders named in this table has sole voting and investment power with respect tonet proceeds that we receive from the sharessale of common stock indicated as beneficially owned. The number of shares of common stock beneficially owned bysuch securities. Pending the selling shareholders also includes shares of common stock currently held by such selling shareholders that were previously purchased on the open market. Such shares of common stock are not being registered pursuant to this prospectus and are not included in the number of shares that may be offered pursuant to this prospectus.


The information set forth below is based on information provided by or on behalfapplication of the selling shareholders prior tonet proceeds, we may invest the date hereof. Information concerning the selling shareholders may change from time to time. The selling shareholders may from time to time offerproceeds in marketable securities and sell any or all of the securities under this prospectus. Because the selling shareholders are not obligated to sell the offered securities, we cannot state with certainty the amount of our securities that the selling shareholders will hold upon consummation of any such sales. In addition, since the date on which the selling shareholders provided this information to us, such selling shareholders may have sold, transferred or otherwise disposed of all or a portion of the offered securities. We are registering the shares to permit each selling shareholder to resell the shares when such shareholder deems appropriate, subject to the restrictions on transfer set forth under “Plan of Distribution.”

None of the selling shareholders nor any of their respective affiliates, officers, directors or principal equity holders has had any material relationship with us or our affiliates within the past three years.



short-term investments.

   Common Stock
Name of selling stockholder  Number of shares beneficially owned 
Number of shares
offered hereby
(1)
 
Number of shares
owned after
completion of
The offering(2)
 
Percent of shares
beneficially owned after the
offering
(3)
 
           
Adage Capital Partners, LP  1,818,460
 1,818,460 
 % 
CVI Investments Inc.(4)
  227,270
 227,270 
 % 
Nineteen77 Global Multi-Strategy Alpha (Levered) Master Limited  34,454
 35,454 
 % 
O’Connor Global Fundamental Market Neutral Long/Short
(Levered) Master Limited
  14,091
 14,091 
 % 
O’Connor Global Fundamental Market Neutral Long/Short Master
Limited
  2,045
 2,045 
 % 
O’Connor Global Multi-Strategy Alpha Master Limited  175,680
 175,680 
 % 


2


(1)Unless otherwise indicated, the selling stockholders may offer any or all of the common stock they beneficially own.

TABLE OF CONTENTS

(2)The selling stockholders have not informed us, and we do not know, when or in what amounts the selling stockholders may offer for sale the shares of common stock pursuant to this offering. Each selling stockholder may choose not to sell any of the shares offered by this prospectus. Because each selling stockholder may offer all, some or none of the shares of common stock that it owns pursuant to this offering, and because there are currently no agreements, arrangements or undertakings with respect to the sale of any such shares, we cannot provide any information or estimates as to the number of shares of our common stock that the selling stockholders will hold after completion of this offering. For purposes of this table, we have assumed that the selling stockholders will have sold all of the securities covered by this prospectus upon the completion of this offering and will not have sold any shares of common stock held by such selling stockholders not covered by this prospectus.
(3)Calculated based on Rule 13d-3 under the Exchange Act, based on 22,565,708 shares outstanding as of April 17, 2017.
(4)Heights Capital Management, Inc., the authorized agent of CVI Investments, Inc. ("CVI"), has discretionary authority to vote and dispose of the shares held by CVI and may be deemed to be the beneficial owner of these shares. Martin Kobinger, in his capacity as Investment Manager of Heights Capital Management, Inc., may also be deemed to have investment discretion and voting power over the shares held by CVI.  Mr. Kobinger disclaims any such beneficial ownership of the shares.  CVI is affiliated with one or more FINRA members.  CVI purchased the shares being registered hereunder in the ordinary course of business and at the time of purchase, had no agreements or understandings, directly or indirectly, with any other person to distribute such shares.




DESCRIPTION OF CAPITAL STOCK

SECURITIES

The following is a general description of the terms and provisions of our capital stock, together with any additional informationthe securities we include in any applicable prospectus supplement or any related free writingmay offer and sell by this prospectus. This summary isThese summaries are not meant to be complete. This prospectus and the applicable prospectus supplement will contain the material terms and conditions of each security. The prospectus supplement may add, update or change the terms and conditions of the securities as described in this prospectus.


Common Stock

Authorized Shares.


Our authorized capital stock consists of 50,000,000 shares of common stock, par value $.01 per share, and 1,000,000 shares of preferred stock, par value $1.00 per share. As of AprilMay 17, 2017,2019, there were (i) 22,565,70823,403,782 shares of common stock outstanding, (ii) 1,063,894821,849 shares of common stock issuable upon exercise of outstanding stock options under our long term incentive plan at a weighted average price of $18.48$23.65 per share, (iii) 488,956390,176 shares of common stock issuable upon vesting of restricted stock units under our long term incentive plan and (iv) 1,402,194124,292 shares of common stock reserved and availablefor future issuance under our stock option plans and long term incentive plan. There are no shares of our preferred stock outstanding and 50,000 shares of our Series A junior participating preferred stock are reserved for issuance upon exercise of rights under our rights agreement.outstanding. The following description of our capital stock is a summary only and is derived from our certificate of incorporation, which is incorporated by reference into this prospectus.


Voting Rights.


Holders of common stock are entitled to one vote on all matters submitted to a vote of our shareholders, including the election of directors. There is no cumulative voting. Therefore, the holders of a majority of the shares of common stock voted in an election of directors can elect all of the directors then standing for election, subject to any rights of the holders of any outstanding preferred stock, if any.


Liquidation.


In the event of any dissolution, liquidation or winding up of our affairs, whether voluntary or involuntary, after payment of our debts and other liabilities and making provision for the holders of outstanding preferred stock, if any, our remaining assets will be distributed ratably among the holders of our common stock.


stock

Pre-emption.


There are no pre-emptive or other rights to subscribe for any of our shares or securities.


Dividends.

   Dividends.

Holders of shares of common stock are entitled to receive dividends, if, as and when such dividends are declared by our Board of Directors out of assets legally available therefor after payment of dividends required to be paid on shares of outstanding preferred stock, if any.


Transfer Agent and Registrar.


The transfer agent and registrar for our common stock is American Stock Transfer and Trust Company.


Preferred Stock


Our Board of Directors has the authority to issue preferred stock in one or more series and to establish the rights and restrictions granted to or imposed on any unissued shares of preferred stock and to fix the number of shares constituting any series without any



further vote or action by our shareholders. Our Board of Directors has the authority, without approval of our shareholders, to issue preferred stock that has voting and conversion rights superior to our common stock, which could have the effect of deterring, delaying or preventing a change in control. We currently have no plans to issue any shares of preferred stock.

The terms and provisions of any preferred stock that may be offered by this prospectus will be described in the applicable prospectus supplement. You should read the certificate of designations relating to the applicable series of preferred stock for additional information before you purchase any preferred stock.


There are 50,000

3

TABLE OF CONTENTS

Warrants

We may issue warrants for the purchase of our debt securities, common stock, preferred stock, or units of two or more of these types of securities. Warrants may be issued independently or together with debt securities, common stock or preferred stock and may be attached to or separate from these securities. Each series of warrants will be issued under a separate warrant agreement. We will distribute a prospectus supplement with regard to each issue or series of warrants. Each such prospectus supplement will describe:

the title of the warrants;
the aggregate number of warrants to be issued and currently outstanding, if any;
the price or prices at which the warrants will be issued;
the number or principal amount of securities purchasable upon exercise of the warrants and the exercise price of each warrant;
the procedures and conditions relating to the exercise of the warrants including:
the date on which the right to exercise the warrants will commence and the date on which the right will expire;
the maximum or minimum number of the warrants which may be exercised at any time; and
any limitations relating to the exchange and exercise of such warrants;
in the case of warrants to purchase our common stock or preferred stock, any provisions for adjustment of the number or amount of shares of our Series A junior participatingcommon stock or preferred stock reserved for issuancereceivable upon exercise of the warrants or the exercise price of the warrants;
in the case of warrants to purchase preferred stock, the designation, stated value and terms, such as liquidation, dividend, conversion and voting rights, of the series of preferred stock purchasable upon exercise of the warrants;
if applicable, the number of warrants issued with each share of our common stock, preferred stock or debt securities, and the date on and after which the warrants and the related securities will be separately transferable;
if applicable, a discussion of any material federal income tax considerations; and
any other material terms of such warrants.

Exercise of Warrants

Each warrant will entitle the holder of the warrant to purchase the securities, at the exercise price as shall be set forth in, or be determinable as set forth in, the prospectus supplement relating to the warrants. Warrants may be exercised at any time up to the close of business on the expiration date set forth in the applicable prospectus supplement. After the close of business on the expiration date, unexercised warrants will become void.

Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the securities purchased upon such exercise. If less than all of the warrants represented by a warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.

Prior to the exercise of any warrants, holders of the warrants will not have any of the rights of holders of the securities purchasable upon exercise, including:

in the case of warrants for the purchase of debt securities, the right to receive payments of principal of, or any premium or interest on, the debt securities purchasable upon exercise, or to enforce covenants in the applicable indenture; or
in the case of warrants for the purchase of common stock or preferred stock, the right to vote or to receive any payments of dividends on the common stock or preferred stock purchasable upon exercise.

Certificates for warrants to purchase securities will be exchangeable for new warrant certificates of different denominations to the extent set forth in the prospectus supplement.

4

TABLE OF CONTENTS

Rights

We may issue rights to purchase our common stock, preferred stock or debt securities that we may offer to our securityholders. The rights may or may not be transferable by the persons purchasing or receiving the rights. In connection with any rights offering, we may enter into a standby underwriting or other arrangement with one or more underwriters or other persons pursuant to which such underwriters or other persons would purchase any offered securities remaining unsubscribed for after such rights offering. Each series of rights will be issued under a separate rights agent agreement to be entered into between us and a bank or trust company, as rights agent, that we will name in the applicable prospectus supplement. The rights agent will act solely as our agent in connection with the rights agreement.and will not assume any obligation or relationship of agency or trust for or with any holders of rights certificates or beneficial owners of rights.

The prospectus supplement relating to any rights that we offer will include specific terms relating to the offering, including, among other matters:

the date of determining the security holders entitled to the rights distribution;

Series A Junior Participating Preferred Stockthe aggregate number of rights issued and the aggregate number of shares of common stock or preferred stock or the aggregate principal amount of debt securities purchasable upon exercise of the rights;

On May 18, 2009,the exercise price;
the conditions to completion of the rights offering;
the date on which the right to exercise the rights will commence and the date on which the rights will expire; and
any applicable federal income tax considerations.

Each right would entitle the holder of the rights to purchase for cash the principal amount of shares of common stock, preferred stock or debt securities at the exercise price set forth in the applicable prospectus supplement. Rights may be exercised at any time up to the close of business on the expiration date for the rights provided in the applicable prospectus supplement. After the close of business on the expiration date, all unexercised rights will become void.

If less than all of the rights issued in any rights offering are exercised, we may offer any unsubscribed securities directly to persons other than our Boardsecurity holders, to or through agents, underwriters or dealers or through a combination of Directors adoptedsuch methods, including pursuant to standby arrangements, as described in the applicable prospectus supplement.

Stock Purchase Contracts

We may issue stock purchase contracts, including contracts obligating holders to purchase from us, and obligating us to sell to the holders, a Preferred Share Purchase Rights Plan (the “Rights Plan”). specified number or variable number of shares of our common stock or preferred stock at a future date or dates. The consideration per share may be fixed at the time stock purchase contracts are issued or may be determined by reference to a specific formula set forth in the stock purchase contracts. The stock purchase contracts may be issued separately or as part of stock purchase units consisting of a stock purchase contract and our debt securities, preferred stock, any other securities described in the applicable prospectus supplement or debt obligations of third parties, including U.S. treasury securities, securing the holders’ obligations to purchase the shares under the stock purchase contracts. The stock purchase contracts may require us to make periodic payments to the holders of the stock purchase units or vice versa, and such payments may be unsecured or prefunded on some basis.

The applicable prospectus supplement will describe the terms of any stock purchase contracts or stock purchase units. Material federal income tax considerations applicable to the stock purchase units and the stock purchase contracts will be discussed in the related prospectus supplement.

Units

We may issue units, which will consist of one or more of common stock, preferred stock, warrants, rights, stock purchase contracts, debt securities or any combination thereof. The applicable prospectus supplement for any units will describe:

all terms of the units and of the shares of common stock, shares of preferred stock, warrants, rights, stock purchase contracts, debt securities or any combination thereof comprising the units, including whether and under what circumstances the securities comprising the units may or may not be traded separately;

5

TABLE OF CONTENTS

a description of the terms of any unit agreement governing the units; and
a description of the provisions for the payment, settlement, transfer or exchange of the units.

Debt Securities and Guarantees

The following description discusses the general terms and provisions of the debt securities that we may offer under this prospectus. The debt securities may be issued as senior debt securities or subordinated debt securities. The indebtedness represented by the senior debt securities will rank equally with all of our other unsecured and unsubordinated debt. The indebtedness represented by the subordinated debt securities will rank junior and be subordinate in right of payment to the prior payment in full of our senior debt, to the extent and in the manner set forth in the applicable prospectus supplement for the securities.

The senior debt securities and the subordinated debt securities will be issued under separate indentures between us and one or more U.S. banking institutions. The trustee for each series of our debt securities will be identified in the applicable prospectus supplement. We may refer to the indenture covering the senior debt securities as the “senior indenture” and the indenture covering the subordinated debt securities as the “subordinated indenture.” Together the senior indenture and the subordinated indenture are called “indentures.”

The form of the indentures are filed as exhibits to the registration statement of which this prospectus is a part. The indentures are subject to and governed by the Trust Indenture Act of 1939, or the Trust Indenture Act, and may be supplemented or amended from time to time following their execution. We have not yet selected a trustee for either of the indentures, and we have not yet executed either indenture. Prior to issuing any debt securities, we will be required to select a trustee for the applicable indenture or indentures, qualify the trustee or trustees under the Trust Indenture Act and execute the applicable indenture or indentures.

The form of each indenture gives us broad authority to set the particular terms of each series of debt securities, including the right to modify certain of the terms contained in the indenture. The particular terms of a series of debt securities and the extent, if any, to which the particular terms of the issue modify the terms of the applicable form of indenture will be described in the prospectus supplement relating to such series of debt securities.

The following summary describes selected provisions of the Rights Planindentures. This summary does not purportdescribe every aspect of the debt securities or the applicable indenture and is subject to, be complete and is qualified in its entirety by reference to, that certain Rights Agreement dated asall the provisions of May 18, 2009, between the Companyapplicable indenture, including the terms defined in the applicable indenture. We urge you to read the applicable indenture in its entirety. This summary is also subject to, and the Rights Agent (the “Rights Agreement”) (incorporatedqualified in its entirety by reference to, Exhibit 4.1the description of the particular debt securities in the applicable prospectus supplement.

General.

The indentures provide that we will be able to issue an unlimited aggregate principal amount of debt securities under the indentures, in one or more series, and in any currency or currency units. We are not required to issue all debt securities of one series at the same time and, unless otherwise provided, we may reopen a series, without the consent of the holders of the debt securities of that series, for issuances of additional debt securities of that series.

Prior to the issuance of each series of debt securities, the terms of the particular securities will be specified in a supplemental indenture or a resolution of our Current Reportboard of directors or in one or more officer’s certificates pursuant to a board resolution. We will describe in the applicable prospectus supplement the terms of the debt securities being offered, including:

the title, and the price at which we will sell, the offered debt securities;
whether the offered debt securities are senior debt securities or subordinated debt securities;
the aggregate principal amount of the offered debt securities;
the date or dates on Form 8-K dated May 19, 2009).which principal will be payable or how to determine such date or dates;
In connection with the Rights Plan, our Boardrate or rates or method of Directors declared a dividenddetermination of one preferred shareinterest;
the date from which interest will accrue;
the dates on which interest will be payable and any record dates for the interest payable on the interest payment dates;

6

TABLE OF CONTENTS

the place of payment on the offered debt securities;
any obligation or option we have to redeem, purchase right (the “Rights”) for each outstanding shareor repay the offered debt securities, or any option of common stock at the close of business on May 29, 2009 (the “Record Date”). Each Right entitles the registered holder thereof, afterto require us to redeem or repurchase offered debt securities, and the Rights become exercisableterms and until May 18, 2019 (orconditions upon which the earlier redemption, exchangeoffered debt securities will be redeemed, purchased or terminationrepaid;
the currency or currencies, including composite currencies or currency units, in which payment of the Rights),principal of (or premium, if any) or interest, if any, on any of the offered debt securities will be payable if other than the currency of the United States of America;
any index, formula or other method used to purchase fromdetermine the Company one one-thousandth (1/1,000th)amount of principal, premium, if any, or interest;
the terms and conditions upon which payment on the offered debt securities may change;
whether the offered debt securities are defeasible;
any addition to or change in the events of default;
any addition to or change in the covenants in the applicable indenture;
the terms of any right to convert the offered debt securities into common shares; and
any other terms of the offered debt securities not inconsistent with the provisions of the applicable indenture.

If the offered debt securities are denominated in whole or in part in any currency other than U.S. dollars, if the principal of (and premium, if any) or interest, if any, on the offered debt securities are to be payable in a currency or currencies other than that in which the debt securities are to be payable, or if any index is used to determine the amount of payments of principal of (and premium, if any) or interest on any series of the debt securities, material federal income tax, accounting and other considerations applicable thereto will be described in the applicable prospectus supplement.

If so provided in the applicable prospectus supplement, we may issue our debt securities at a discount below their principal amount and pay less than the entire principal amount of our debt securities upon declaration of acceleration of their maturity. The applicable prospectus supplement will describe all material federal income tax, accounting and other considerations applicable to any such original issue discount securities.

The general provisions of the indentures do not contain any provisions that would limit our ability or the ability of our subsidiaries to incur indebtedness or that would afford holders of our debt securities protection in the event of a Series A Junior Participating Preferred Share, par value $1.00 per share (the “Preferred Shares”), at a price of $80.00 per one one-thousandth (1/1,000th) of a Preferred Share, subject to certain anti-dilution adjustments (the “Purchase Price”). Until the earlier to occur of (i) the tenth business day following a public announcement that a personhighly leveraged or group of affiliatedsimilar transaction involving us or associated persons has acquired, or obtained the right to acquire, beneficial ownership of 20% or more of the common stock (an “Acquiring Person”) or (ii) the tenth business day (or such later date as may be determined by actionany of our Board of Directors priorsubsidiaries. Please refer to such time as any person or group of affiliated persons becomes an Acquiring Person) following the commencement or announcement of an intention to make a tender offer or exchange offer the consummation of which would result in the beneficial ownership by a person or group of 20% or more of the common stock (the earlier of (i) and (ii) being called the “Distribution Date”), the Rights are evidenced,applicable prospectus supplement for information with respect to any deletions from, modifications of the common stock certificates outstanding as of the Record Date, by such common stock certificate (or, with respect to any common stock held in book entry form, by the notation in book entry). The Rights Agreement provides that any person, who immediately prioror additions to, the first public announcementevents of the adoption of the Rights Agreement, beneficially owned 20% or more of the common stock then outstanding, together with any respective affiliates and associates ofdefault described below that person (each an “Existing Holder”), shall not be deemed to be an “Acquiring Person” for purposes of the Rights Agreement unless the Existing Holder becomes the beneficial owner of (x) a percentage of the common stock of the Company then outstanding that is more than the aggregate percentage of the outstanding common stock that such Existing Holder beneficially owns as of the date immediately priorare applicable to the first public announcement ofoffered debt securities or any covenants or other provisions providing event risk or similar protection.

   Payment.

Unless we state otherwise in the adoption ofapplicable prospectus supplement, we will pay interest on a debt security on each interest payment date to the Rights Agreement or (y) less than 20% ofperson in whose name the common stock of the Company then outstanding (after which, if the Existing Holder becomes the beneficial owner of 20% or more of the common stock of the Company then outstanding, the Existing Holder shall be deemed to be an “Acquiring Person”).

The Rights are transferred only with the common stock until the Distribution Date or earlier redemption or expiration of the Rights. As soon as practicable following the Distribution Date, separate certificates evidencing the Rights (“Right Certificates”) will be mailed to holders of record of the common stockdebt security is registered as of the close of business on the Distribution Dateregular record date relating to the interest payment date.

Unless we state otherwise in the applicable prospectus supplement, we will pay principal of and such separate Right Certificates alone will evidenceany premium on the Rights. The Rights willdebt securities at no time have any voting rights.

Each Preferred Share purchasablestated maturity, upon exerciseredemption or otherwise, upon presentation of the Rightsdebt securities at the office of the applicable trustee, as our paying agent, or at other designated places. Any other paying agent initially designated for the debt securities of a particular series will be entitled, when, asidentified in the applicable prospectus supplement.

   Form, Transfers and if declared, to a minimum preferential quarterly dividend payment equalExchanges.

The debt securities of each series will be issued only in fully registered form, without interest coupons. Unless we state otherwise in the applicable prospectus supplement, the debt securities will be issued in denominations of $1,000 each or multiples thereof.

Subject to the greater of (a) $1.00 per share or (b) 1,000 times the dividend, if any, declared per share of common stock. In the event of liquidation, dissolution or winding upterms of the Company,applicable indenture and the holderslimitations applicable to global securities, you may exchange or transfer debt securities at the corporate trust office of the Preferred Sharestrustee or at any other office or agency maintained by us for that purpose, without the payment of any service charge, except for any tax or governmental charge.

7

TABLE OF CONTENTS

   Global Securities.

The debt securities of any series may be issued, in whole or in part, by one or more global certificates that will be entitled to a preferential liquidation payment of $1,000 per share plus any accrued but unpaid dividends, provided that the holders of the Preferred Shares shall be entitled to 1,000 times the payment made per share of common stock. Each Preferred Share will have 1,000 votes and will vote togetherdeposited with the shares of common stock. Finally,depositary identified in the eventapplicable prospectus supplement.

No global security may be exchanged in whole or in part for the debt securities registered in the name of any merger, consolidationperson other than the depositary for that global security or other transactionany nominee of that depositary except in which the common stock are exchanged, each Preferred Share will be entitledfollowing circumstances or as otherwise provided in the applicable prospectus supplement. The depositary may discontinue providing its services as depositary with respect to receive 1,000 times the amount received per share of common stock. Preferred Shares will not be redeemable. The Rights are protectedsecurities at any time by customary anti-dilution provisions. Because ofgiving reasonable notice to us or the nature of the Preferred Share’s dividend, liquidation and voting rights, the value of one one-thousandth of a Preferred Share purchasable upon exercise of each Right should approximate the value of one share of common stock.


Inapplicable trustee. Under such circumstances, in the event that a person becomessuccessor depositary is not obtained, certificates are required to be printed and delivered. In addition, we may decide to discontinue use of the system of book-entry-only transfers through a depositary. In that event, certificates will be printed and delivered to the depositary.

Unless otherwise stated in any prospectus supplement, The Depository Trust Company, or DTC, will act as depositary. Beneficial interests in global certificates will be shown on, and transfers of global certificates will be effected only through records maintained by DTC and its participants.

   Events of Default.

Unless otherwise specified in the applicable prospectus supplement, an Acquiring Personevent of default occurs with respect to debt securities of any series if:

we do not pay any interest on any debt securities of the applicable series within 30 days of the due date (following any deferral allowed under the terms of the debt securities and elected by us);
we do not pay principal or premium, if any, on any debt securities of the applicable series at maturity;
we do not deposit any sinking fund payment when due by the terms of the applicable debt securities;
we default in the performance, or are in breach, of a covenant or warranty of the applicable indenture (other than a covenant or warranty default or breach that is elsewhere specifically dealt with or which expressly has been included in the applicable indenture solely for the benefit of debt securities other than that series), and such default or breach continues for a period of 60 days after there has been given by registered or certified mail, to us by the applicable trustee or to us and the applicable trustee by the holders of at least 25% of the principal amount of debt securities of the affected series, a written notice specifying such default or breach and requiring it to be remedied;
certain events of bankruptcy, insolvency, receivership or reorganization with respect to us occur; or
any other event of default provided with respect to debt securities of that series occurs.

No event of default with respect to a series of debt securities necessarily constitutes an event of default with respect to the debt securities of any other series issued under the indentures.

Each indenture requires us to file annually with the applicable trustee an officers’ certificate as to our compliance with all conditions and covenants under the applicable indenture. Each indenture provides that the applicable trustee may withhold notice to the holders of a series of debt securities of any default, except payment defaults on those debt securities, if it considers such withholding to be in the interest of the holders of that series of debt securities.

If an event of default occurs and is continuing with respect to any series of debt securities, then either the applicable trustee or the holders of not less than 25% in principal amount of the outstanding debt securities of that series may declare the principal amount, or, if any debt securities of that series are original issue discount securities, that portion of the Company wereprincipal amount of those original issue discount securities as may be specified in the surviving corporationterms of those original issue discount securities, of all of the debt securities of that series to be due and payable immediately, by a notice in writing to us, and to the applicable trustee if given by the holders, and upon any such declaration that principal amount, or specified amount, plus accrued and unpaid interest, and premium, if any, will become immediately due and payable. Upon payment of that amount in the currency in which the debt securities are denominated (except as otherwise provided in the applicable indenture or the applicable prospectus supplement), all of our obligations in respect of the payment of principal of the debt securities of that series will terminate.

8

TABLE OF CONTENTS

After a merger with an Acquiring Persondeclaration of acceleration has been made and before the trustee has obtained a judgment or decree for payment of the money due on any affiliate or associateseries of an Acquiring Persondebt securities, the holders of not less than a majority in aggregate principal amount of the outstanding debt securities of that series, by written notice to us and the common stock were not changedapplicable trustee, may rescind and annul the declaration and its consequences, subject to any terms or exchanged, each holderconditions specified in the applicable prospectus supplement.

If an event of default results from bankruptcy, insolvency or reorganization, the principal amount of all the debt securities of a Right, other than Rightsseries, or that areportion of the principal amount of such debt securities as may be specified in the applicable prospectus supplement, will automatically become immediately due and payable.

Subject to the provisions of each indenture relating to the duties of the applicable trustee, in case an event of default with respect to our debt securities of a particular series occurs and is continuing, the applicable trustee will be under no obligation to exercise any of its rights or were acquiredpowers under that indenture at the request, order or beneficially owneddirection of any of the holders of debt securities of that series, unless the holders have offered to the applicable trustee reasonable security or indemnity against the costs, expenses and liabilities which might be incurred by it in complying with such request or direction. Subject to the Acquiring Person (which Rightsprovisions for the indemnification of the applicable trustee, the holders of a majority in principal amount of the outstanding debt securities of that series will



thereafter be void), will thereafter have the right to receive upon exercisedirect the time, method and place of conducting any proceeding for any remedy available to the applicable trustee under the applicable indenture, or exercising any trust or power conferred on the applicable trustee with respect to the debt securities of that numberseries.

   Merger or Consolidation.

Each indenture provides that we may not consolidate with or merge or wind up into any other entity, whether or not we are the surviving entity, and that we may not sell, assign, convey, transfer or lease our properties and assets substantially as an entirety to any person, unless:

the entity formed by the consolidation or into which we are merged, or the person which acquires us or which leases our properties and assets substantially as an entirety, is an entity organized and existing under the laws of sharesthe United States of common stock having a market valueAmerica or any State or territory of two times the then current Purchase PriceUnited States or the District of one Right. InColumbia, and expressly assumes, by supplemental indenture, the due and punctual payment of the principal of (and premium, if any) and interest on all the outstanding debt securities and the performance of all of our covenants under the applicable indenture;
immediately after giving effect to such transaction, no event that,of default under the applicable indenture, and no event which after a person hasnotice or lapse of time or both would become an Acquiring Person,event of default, has happened and is continuing; and
all other conditions specified in the Company were acquired in a mergerapplicable prospectus supplement are met.

   Modification or Waiver.

Without prior notice to or the consent of any holders, we and the applicable trustee may modify the applicable indenture for any of the following purposes:

to evidence the succession of another entity to us and the assumption by that successor of our covenants and obligations under the applicable indenture and under our debt securities issued thereunder;
to add one or more covenants or other business combination transaction or more than 50% of its assets or earning power were sold, proper provision shall be made so that each holder of a Right shall thereafter haveprovisions for the right to receive, upon the exercise thereof at the then current Purchase Price of the Right, that number of shares of common stock of the acquiring company which at the time of such transaction would have a market value of two times the then current Purchase Price of one Right.
At any time after a person becomes an Acquiring Person and prior to the earlier of one of the events described in the last sentence in the previous paragraph or the acquisition by such Acquiring Person of 50% or more of the then outstanding common stock, our Board of Directors may cause the Company to exchange the Rights (other than Rights owned by an Acquiring Person which have become void) for shares of common stock on a 1:1 basis.
The Rights may be redeemed in whole, but not in part, at a price of $0.01 per Right (the “Redemption Price”) by our Board of Directors at any time prior to the time that an Acquiring Person has become such. The redemption of the Rights may be made effective at such time, on such basis and with such conditions as our Board of Directors in its sole discretion may establish. Immediately upon any redemption of the Rights, the right to exercise the Rights will terminate and the only rightbenefit of the holders of Rights willall or any series of debt securities, and if those covenants are to be for the benefit of less than all series, stating that those covenants are expressly being included solely for the benefit of that series, or to receivesurrender any right or power conferred upon us;
to add any additional events of default for all or any series of debt securities, and if those events of default are to be applicable to less than all series, stating that those events of default are expressly being included solely to be applicable to that series;
to change or eliminate any provision of the Redemption Price.
The Rights will expire on May 18, 2019applicable indenture or earlier if the rights are redeemed or exchanged, or, upon the closing of a merger or acquisition transaction that is approved by our Board of Directors priorto add any new provision to the time at which person or group acquires 20% or more of the common stock.
The Purchase Price payable, and the number of one one-thousandth of a Preferred Share or other securities or property issuable, upon exercise of the Rights are subject to adjustment from time to time to prevent dilution (i) in the event of a stock dividend on, or a subdivision, combination or reclassification of, the Preferred Shares, (ii) upon the grant to holders of the Preferred Shares of certain rights or warrants to subscribe for or purchase Preferred Shares or convertible securities at less than the current market price of the Preferred Shares or (iii) upon the distribution to holders of the Preferred Shares of evidences of indebtedness, cash, securities or assets (excluding regular periodic cash dividends at a rate not in excess of 125% of the rate of the last regular periodic cash dividend theretofore paid or, in case regular periodic cash dividends have not theretofore been paid, at a rate not in excess of 50% of the average net income per share of the Company for the four quarters ended immediately prior to the payment of such dividend, or dividends payable in Preferred Shares (which dividends will be subject to the adjustment described in clause (i) above)) or of subscription rights or warrants (other than those referred to above).

Until a Right is exercised, the holder thereof, as such, will have no rights as a shareholder of the Company beyond those as an existing shareholder, including, without limitation, the right to vote or to receive dividends.
Any of the provisions of the Rights Agreement may be amended by our Board of Directors for so long as the Rights are then redeemable, and after the Rights are no longer redeemable, the Company may amend or supplement the Rights Agreement in any mannerapplicable indenture that does not adversely affect the interests of the holders;
to provide security for the debt securities of any series or to provide that any of our obligations under the debt securities or the applicable indenture shall be guaranteed and the terms and conditions for the release or substitution of the security or guarantee;

9

TABLE OF CONTENTS

to supplement any of the provisions of the applicable indenture to the extent necessary to permit or facilitate the defeasance and discharge of any series of debt securities, provided, that any such action will not adversely affect the interests of the holders of debt securities of that series or any other series of debt securities issued under the applicable indenture in any material respect;
to establish the form or terms of debt securities of any series as permitted by the applicable indenture;
to evidence and provide for the acceptance of appointment of a separate or successor trustee with respect to one or more series of debt securities and to add to or change any of the provisions of the applicable indenture as is necessary to provide for or facilitate the administration of the trusts thereunder by more than one trustee;
to cure any ambiguity, defect or inconsistency;
to eliminate any conflict between the terms of the applicable indenture and the debt securities issued thereunder and the Trust Indenture Act; or
to modify any other provisions with respect to matters or questions arising under the applicable indenture that will not be inconsistent with any provision of the applicable indenture, provided, those other provisions do not adversely affect the interests of the holders of our outstanding debt securities of any series created thereunder prior to such modification in any material respect.

We and the applicable trustee may, with some exceptions, amend or modify either indenture with the consent of the holders of at least a majority in aggregate principal amount of the outstanding debt securities of all series affected by the amendment or modification. However, no amendment or modification may, without the consent of the holder of each outstanding debt security affected thereby:

change the Rights.
One Right was distributed to shareholdersstated maturity of the Companyprincipal of or interest on any debt security (other than pursuant to the terms of the debt security), reduce the principal amount, premium or interest payable upon redemption, change the currency in which any debt security is payable, or impair the right to bring suit to enforce any payment;
reduce the percentages of holders whose consent is required for any modification or waiver or reduce the requirements for quorum and voting under the applicable indenture; or
modify certain of the provisions in the applicable indenture relating to supplemental indentures and waivers of certain covenants and past defaults.

A modification which changes or eliminates any provision of an indenture expressly included solely for the benefit of holders of debt securities of one or more particular series or modifies the holders’ rights will be deemed not to affect the rights under the indenture of the registered holders of debt securities of any other series.

Each of the indentures provides that the holders of not less than a majority in aggregate principal amount of the then outstanding debt securities of any series, by notice to the relevant trustee, may on behalf of the holders of the debt securities of that series waive any default or event of default and its consequences under the applicable indenture, except:

a continuing default or event of default in the payment of the principal of (and premium, if any) or interest on any such debt security held by a non-consenting holder; or
a default in respect of a covenant or provision of the indenture which cannot be modified or amended without the consent of the holder of each outstanding debt security of each series affected.

   Legal Defeasance and Covenant Defeasance.

The applicable indenture with respect to the debt securities of any series may be discharged, subject to the terms and conditions as specified in the applicable prospectus supplement, when either:

all debt securities, with the exceptions provided for in the applicable indenture, of that series have been delivered to the applicable trustee for cancellation;
all debt securities of that series not theretofore delivered to the applicable trustee for cancellation:
have become due and payable;

10

TABLE OF CONTENTS

will become due and payable at their stated maturity within one year; or
are to be called for redemption within one year; or
certain events or conditions occur as specified in the applicable prospectus supplement.

In addition, each series of debt securities may provide additional or different terms or conditions for the discharge or defeasance of some or all of our obligations as may be specified in the applicable prospectus supplement.

If provision is made for the defeasance of debt securities of a series, and if the debt securities of that series are registered securities and denominated and payable only in U.S. dollars, then the provisions of each indenture relating to defeasance will be applicable except as otherwise specified in the applicable prospectus supplement for debt securities of that series. Defeasance provisions, if any, for debt securities denominated in a foreign currency or currencies may be specified in the applicable prospectus supplement.

At our option, either (i) we will be deemed to have been discharged from our obligations with respect to debt securities of any series, i.e., the “legal defeasance option,” or (ii) we will cease to be under any obligation to comply with certain provisions of the applicable indenture with respect to certain covenants, if any, specified in the applicable prospectus supplement with respect to debt securities of any series, i.e., the “covenant defeasance option,” at any time after the conditions specified in the applicable prospectus supplement have been satisfied.

   Senior Debt Securities.

The senior debt securities will be unsecured senior obligations and will rank equally with all other senior unsecured and unsubordinated debt. The senior debt securities will, however, be subordinated in right of payment to all of our secured indebtedness to the extent of the value of the assets securing that indebtedness. Except as provided in the senior indenture or specified in any authorizing resolution or supplemental indenture relating to a series of senior debt securities to be issued, no senior indenture will limit the amount of additional indebtedness that may rank equally with the senior debt securities or the amount of indebtedness, secured or otherwise, that may be incurred or preferred shares that may be issued by any of our subsidiaries.

   Subordination.

If our assets are distributed upon our dissolution, winding up, liquidation or reorganization, the payment of the principal of (and premium, if any) and interest on any subordinated debt securities will be subordinated in right of payment, to the extent provided in the subordinated indenture and the applicable prospectus supplement, to the prior payment in full of all senior indebtedness, including senior debt securities. However, our obligation to pay the principal of (and premium, if any) or interest on the subordinated debt securities will not otherwise be affected. Unless otherwise stated in the applicable prospectus supplement, payment on account of principal (or premium, if any), sinking funds or interest on the subordinated debt securities may not be made at any time when there is a default in the payment of the principal, premium, if any, sinking funds, interest or certain other obligations on senior indebtedness. In addition, the prospectus supplement for any series of subordinated debt securities may provide that payments of the principal of (or premium, if any) or interest on the subordinated debt securities may be delayed or not paid under specified circumstances and periods. If, while we are in default on senior indebtedness, any payment is received by the trustee under the subordinated indenture or the holders of any of the subordinated debt securities before we have paid all senior indebtedness in full, the payment or distribution must be paid over to the holders of the unpaid senior indebtedness or applied to the repayment of the unpaid senior indebtedness. Subject to paying the senior indebtedness in full, the holders of the subordinated debt securities will be subrogated to the rights of the holders of the senior indebtedness to the extent that payments are made to the holders of senior indebtedness out of the distributive share of common stock ownedthe subordinated debt securities.

Due to the subordination, if our assets are distributed upon insolvency, some or all of recordour general creditors may recover more, ratably, than holders of subordinated debt securities. The subordinated indenture or applicable supplemental indenture may state that its subordination provisions will not apply to money and securities held in trust under the satisfaction and discharge and the legal defeasance provisions of the subordinated indenture.

If this prospectus is being delivered in connection with the offering of a series of subordinated debt securities, the applicable prospectus supplement or the information incorporated by reference in it will specify the approximate amount of senior indebtedness outstanding as of a recent date and any limitations on the issuance of additional senior indebtedness (or that there is not such limitation). Senior indebtedness with respect to any series of subordinated debt securities will have the meaning specified in the applicable prospectus supplement for that series.

11

TABLE OF CONTENTS

   Corporate Existence.

Subject to the terms of the applicable indenture, we will do or cause to be done all things necessary to preserve and keep in full force and effect our corporate existence, charter and statutory rights and franchises; provided, however, that we will not be required to preserve any right or franchise if we determine that the preservation thereof is no longer desirable in the conduct of our business.

   Governing Law.

The indentures and our debt securities will be governed by, and construed in accordance with, the law of the State of New York.

   Guarantees.

If the applicable prospectus supplement relating to a series of debt securities provides that those debt securities will have the benefit of a guarantee by the Company’s then existing or future domestic subsidiaries, then the debt securities will be fully and unconditionally guaranteed by such guarantor subsidiaries. In the event of a bankruptcy, liquidation or reorganization of any of the non-guarantor subsidiaries, the non-guarantor subsidiaries will pay the holders of their debt and their trade creditors before they will be able to distribute any of their assets to us. The guarantees will be general obligations of each guarantor. The guarantees will be joint and several obligations of the guarantors. If a series of debt securities is so guaranteed, a supplemental indenture to the applicable base indenture will be executed by each guarantor. The Subsidiary Guarantors are guarantors under the indenture governing our existing senior notes and our existing senior credit facilities. The obligations of each guarantor under its guarantee will be limited as necessary to prevent that guarantee from constituting a fraudulent conveyance under applicable law. The terms of any guarantee and the conditions upon which any guarantor may be released from its obligations under that guarantee will be set forth in the applicable prospectus supplement.

12

TABLE OF CONTENTS

PLAN OF DISTRIBUTION

The securities that may be offered by this prospectus may be sold:

through agents;
to or through underwriters;
to or through broker-dealers (acting as agent or principal);
in “at the market offerings” within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market, on an exchange, or otherwise;
directly to purchasers, through a specific bidding or auction process or otherwise; or
through a combination of any such methods of sale.

Agents, underwriters or broker-dealers may be paid compensation for offering and selling the securities. That compensation may be in the form of discounts, concessions or commissions to be received from us, from the purchasers of the securities or from both us and the purchasers. The compensation received may be in excess of customary discounts, concessions or commissions. Any underwriters, dealers, agents or other investors participating in the distribution of the securities may be deemed to be “underwriters,” as that term is defined in the Securities Act, and compensation and profits received by them on May 29, 2009. As long as the Rights are attached to the common stock, the Company will issue one Right with each new share of common stock so that all such shares will have attached Rights. The Company has agreed that, from and after the Distribution Date, the Company will reserve 50,000 Preferred Shares initially for issuance upon exercisesale of the Rights.

The Rightssecurities may be deemed to be underwriting commissions, as that term is defined in the rules promulgated under the Securities Act.

Each time the securities are designed to assure that alloffered by this prospectus, the prospectus supplement, if required, will set forth:

the name of any underwriter, dealer or agent involved in the offer and sale of the Company’s shareholders receive fair and equal treatment in securities;
the event of any proposed takeoverterms of the Company and to guard against partial tender offers, open market accumulationsoffering;
any discounts, concessions or commissions and other abusiveitems constituting compensation received by the underwriters, broker-dealers or coercive tacticsagents;
any over-allotment option under which any underwriters may purchase additional securities from us;
any initial public offering price;
any discounts or concessions allowed or re-allowed or paid to gain control of the Company without paying all shareholders a control premium. The Rights will cause substantial dilution to a person or group that acquires 20%or more of the Company’s stock on terms not approved by our Board of Directors. The Rights should not interfere with dealers;
any merger or other business combination approved by our Board of Directors at any time prior to the first date that a person or group has become an Acquiring Person.





PLAN OF DISTRIBUTION
The selling shareholders, which as used herein includes donees, pledgees, transferees or other successors in interest selling shares of common stock or interests in shares of common stock received after the date of this prospectus from a selling shareholder as a gift, pledge, partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares of common stock or interests in shares of common stock on any stock exchange, market or trading facilitysecurities exchanges on which the shares are traded or in private transactions. These dispositionssecurities may be listed; and
the anticipated date of delivery of the securities.

The securities may be sold at a fixed price or prices, which may be changed, at prevailing market prices prevailing at the time of sale, at prices relatedrelating to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.


The selling shareholdersdistribution of securities may dispose of shares or interests thereinbe effected from time to time in one or more typestransactions, by means of transaction,one or more of the following transactions, which may include:include crosses or block trades:

exchange offers or other transactions on the Nasdaq Global Select Market or any other organized market where the securities may be traded;

purchases by underwriters, dealers and agents who may receive compensation in the formover-the-counter market;
in negotiated transactions;
through put or call option transactions relating to the securities;
under delayed delivery contracts or other contractual commitments; or
a combination of underwriting discounts, concessions or commissions for the selling shareholders and/or the purchaserssuch methods of thesale.

If underwriters are used in a sale, securities for whom they may act as agent;


ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction, or in crosses, in which the same broker acts as agent on both sides of the trade;

purchases by a broker-dealer as principal and resalebe acquired by the broker-dealerunderwriters for its account;

the pledge of securities for any loan or obligation, including pledges to brokers or dealers whotheir own account and may be resold from time to time effect distributions of securities;

in one or more exchangestransactions. Securities may be offered to the public either through underwriting syndicates represented by one or over-the-counter market transactions;

distributions to equity holdersmore managing underwriters or creditors of the selling shareholders;

directly by one or more firms acting as underwriters. If an exchange distributionunderwriter or underwriters are used in accordance with the rules of the applicable exchange;

privately negotiated transactions;

short sales effected after the date the registration statement of which this Prospectus is a part is declared effective by the SEC;

through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;

    broker-dealers may agree with the selling shareholders to sell a specified number of such shares at a stipulated price per share;

a combination of any such methods of sale; and

any other method permitted by applicable law.

The selling shareholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending the list of selling shareholders to include the pledgee, transferee or other successors in interest as selling shareholders under this prospectus. The selling shareholders also may transfer the shares of common stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.

In connection with the sale of our common stocksecurities, an underwriting agreement will be executed with the underwriter or interests therein,underwriters at the selling shareholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling shareholders may also sell shares of our common stock short and deliver these


securities to close out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling shareholders may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The aggregate proceeds to the selling shareholders fromtime an agreement for the sale ofis reached. This prospectus and the common stock offered by themprospectus supplement will be the purchase price of the common stock less discounts or commissions, if any. Each of the selling shareholders reserves the right to accept and, together with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from this offering.

The selling shareholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act of 1933, provided that they meet the criteria and conform to the requirements of that rule.

In connection with sales of securities covered hereby, the selling shareholders and any underwriter, broker-dealer or agent and any other participating broker-dealer that executes sales for the selling shareholders may be deemed to be an “underwriter” within the meaning of the Securities Act. Accordingly, any profits realizedused by the selling shareholders and any compensation earned by such underwriter, broker-dealer or agent may be deemedunderwriters to be underwriting discounts and commissions. Selling shareholders who are “underwriters” underresell the Securities Act must deliver this prospectus in the manner required by the Securities Act. This prospectus delivery requirement may be satisfied through the facilities of the NASDAQ Stock Market in accordance with Rule 153 under the Securities Act or satisfied in accordance with Rule 174 under the Securities Act.securities.


To the extent required, the shares of our common stock to be sold, the names of the selling shareholders, the respective purchase prices and public offering prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.

13


In order to

TABLE OF CONTENTS

To comply with the securities laws of somecertain states, if applicable, the common stock maysecurities offered by this prospectus will be offered and sold in these jurisdictionsthose states only through registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from registration or qualification requirements is available

Agents, underwriters and is complied with.

We have advised the selling shareholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling shareholders and their affiliates. In addition, to the extent applicable we will make copies of this prospectus (as itdealers may be supplemented or amended from timeentitled under agreements entered into with us to time) available to the selling shareholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling shareholders may indemnify any broker-dealer that participates in transactions involving the sale of the sharesindemnification by us against certainspecified liabilities, including liabilities arising under the Securities Act.

We have agreed to indemnify the selling shareholders against liabilities, including liabilitiesincurred under the Securities Act, and state securities laws, relatingor to the registration of the shares offeredcontribution by this prospectus.

In connection with an offering of securities under this prospectus, the underwriters may purchase and sell securities in the open market. These transactions may include short sales, stabilizing transactions and purchasesus to cover positions created by short sales. Short sales involve the sale by the underwriters of a greater number of securities than they are required to purchase in an offering. Stabilizing transaction consist of certain bids or purchases made for the purpose of preventing or retarding a decline in the market price of the securities while an offering is in progress.

The underwriters also may impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the underwriters have repurchased securities sold by or for the account of that underwriter in stabilizing or short-covering transactions.

These activities by the underwriters may stabilize, maintain or otherwise affect the market price of the securities offered under this prospectus. As a result, the price of the securities may be higher than the price that otherwise might exist in the open market. If these activities are commenced,payments they may be discontinued byrequired to make in respect of such liabilities. The prospectus supplement will describe the terms and conditions of such indemnification or contribution. Some of the agents, underwriters at any time. These transactionsor dealers, or their respective affiliates may be effected on the NASDAQ Stock Marketcustomers of, engage in transactions with or another securities exchange or automated quotation system, orperform services for us in the over-the-counter market or otherwise.



ordinary course of business. We will describe in the prospectus supplement naming the underwriter the nature of any such relationship.

Our common stock is listed on the NASDAQNasdaq Global Market under the symbol “CMCO.” On April 21, 2017, the closing price of our common stock as reported on the NASDAQ Global Market was $25.44 per share.


LEGAL MATTERS
DLA Piper LLP (US), New York, New York will pass for us upon the validity of the securities being offered by this prospectus and applicable prospectus supplement, and counsel namedSelect Market. Unless otherwise specified in the applicable prospectus supplement, each other class or series of securities issued will pass upon legal mattersbe a new issue with no established trading market. We may elect to list any other class or series of securities on any exchange, but we are not currently obligated to do so. It is possible that one or more underwriters, if any, may make a market in a class or series of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market for any underwriters, dealersof the securities.

Certain persons participating in the offering may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Exchange Act. We make no representation or agents.prediction as to the direction or magnitude of any effect that such transactions may have on the price of the securities. For a description of these activities, see the information under the heading “Underwriting” in the applicable prospectus supplement.

EXPERTS

14


TABLE OF CONTENTS

LEGAL MATTERS

The validity of the securities offered in this prospectus will be passed upon for us by Hodgson Russ LLP.

EXPERTS

The consolidated financial statements of Magnetek, Inc. appearing in Magnetek, Inc.’s Annual Report (Form 10-K) for the year ended December 28, 2014 (including the schedule appearing therein), the consolidated financial statements of Columbus McKinnon Corporation appearing in Columbus McKinnon Corporation’s Annual Report (Form 10-K)on Form 10-K for the year ended March 31, 20162019 (including the schedule appearing therein), and the effectiveness of the Columbus McKinnon Corporation’s internal control over financial reporting as of March 31, 20162019 have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their reports thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such reports given uponon the authority of such firm as experts in accounting and auditing.


WHERE YOU CAN FIND ADDITIONAL INFORMATION

We have filed a registration statement on Form S-3 under the Securities Act with the SEC to register the securities offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules which are a part of the registration statement. For further information with respect to us and our securities, please refer to the registration statement and the exhibits and schedules filed with it. You may read and copy any document which we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.


We are also subject to the information and periodic reporting requirements of the Exchange Act and file annual, quarterly and current reports, proxy statements, and other information with the SEC and these reports, proxy statements, and other information can be inspected on the Internet site maintained by the SEC at http://www.sec.gov.

We also maintain a website at www.cmworks.com. However, the information on our website is not part of this prospectus.

15

TABLE OF CONTENTS

INFORMATION INCORPORATED BY REFERENCE

The SEC allows us to “incorporate by reference” information into this prospectus. This means that we can disclose important information about us and our financial condition to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be part of this prospectus except for any information superseded by information contained expressly in this prospectus, and the information we file later with the SEC will automatically supersede this information. You should not assume that (i) the information incorporated by reference in this prospectus is accurate as of any date other than the respective date of the documents incorporated by reference or (ii) the information contained in this prospectus is accurate as of any date other that the date on the front page of this prospectus.

This prospectus incorporates by reference the documents listed below that we have previously filed with the SEC:



our Annual Report on Form 10-K for the fiscal year ended March 31, 2016;2019;
our Quarterly Reports on Form 10-Q for the fiscal quarters ended June 30, September 30 and December 31, 2016;
our Current Report on Form 8-K filed with the SEC on September 2, 2015, as amended by our Amended Current Report on Form 8-K/A filed with the SEC on November 9, 2015, our Current Reports on Form 8-K filed on April 1, June 1, July 19, July 28, September 15, October 24, October 28, December 7 and December 19, 2016, our Current Reports on Form 8-K filed on January 5, January 9 and January 23, 2017, our Current Report on Form 8-K filed on January 31, 2017, as amended by our Amended Current Report on Form 8-K/A filed with the SEC on April 13, 2017, and our Current Reports filed on February 28, 2017 and March 28, 2017;
the description of our common stock contained in our Registration Statement on Form 8-A, filed with the SEC on January 24, 1996, as amended by Amendment No. 1 thereto on Form 8-A/A filed with the SEC on February 22, 1996 and any amendment or report filed with the SEC for the purpose of updating the description; and
the description of the preferred share purchase rights associated with our common stock contained in our Registration Statement on Form 8-A, filed with the SEC on May 19, 2009, and any amendment or report filed with the SEC for the purpose of updating the description.29, 2019.

the description of our Common Stock contained in our Registration Statement on Form 8-A, filed with the SEC on January 24, 1996, as amended by Amendment No. 1 thereto on Form 8-A/A filed with the SEC on February 22, 1996 and any amendment or report filed with the SEC for the purpose of updating the description.

We also incorporate by reference all documents that we subsequently file with the SEC after the filing of this prospectus, including documents filed on and after the date of the initial registration statement and prior to effectiveness of the registration statement, pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act and prior to the sale of all securities registered hereunder or termination of the registration statement. Nothing in this prospectus shall be deemed to incorporate information furnished but not filed with the SEC.


Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference in this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained herein or in the applicable prospectus supplement or in any other subsequently filed document which also is or is deemed to be incorporated by reference modifies or supersedes the statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus.


You may request a copy of the filings incorporated herein by reference, including exhibits to such documents that are specifically incorporated by reference, at no cost, by writing or calling us at the following address or telephone number:


Alan S. Korman


Vice President, General Counsel and Corporate Secretary

Columbus McKinnon Corporation

205 Crosspoint Parkway

Getzville, New York 14068

Telephone: (716) 689-5400

Statements contained in this prospectus as to the contents of any contract or other documents are not necessarily complete, and in each instance investors are referred to the copy of the contract or other document filed as an exhibit to the registration statement, each such statement being qualified in all respects by such reference and the exhibits and schedules thereto.


Neither we nor the selling shareholders have authorized anyone to provide you with information different from that contained or incorporated by reference in this prospectus, any prospectus supplement or any free writing prospectus prepared by us or on our behalf. Neither we nor the selling stockholders take any responsibility for, or can provide any assurance as to the reliability of, any information other than the information contained or incorporated by reference in this prospectus, any prospectus supplement or any free writing prospectus prepared by us or on our behalf. The selling shareholders are not offering to sell, nor seeking offers to buy, shares of common stock in any jurisdiction where an offer or sale is not permitted.

16



TABLE OF CONTENTS



PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14.Other Expenses of Issuance and Distribution.

The following table itemizes the fees and expenses incurred or expected to be incurred by the registrant in connection with the issuance and distribution of the securities being registered, other than underwriting discounts and commissions.

Item
Amount
Securities and Exchange Commission registration fee
$
36,360.00
 
Legal fees and expenses
 
 
*
Accounting fees and expenses
 
 
*
Printing fees and expenses
 
 
*
Rating agencies fees
 
 
*
Trustee fees (including counsel fees)
 
 
*
Miscellaneous fees and expenses
 
 
*
Total
 
 
*
ItemAmount
Securities and Exchange Commission registration fee$6,530
Legal fees and expenses*
Accounting feesEstimated expenses are not presently known because they depend upon, among other things, the number of offerings that will be made pursuant to this registration statement, the amount and expenses*
Printing feestype of securities being offered and the timing of such offerings. The foregoing sets forth the general categories of expenses*
Rating agencies fees*
Trustee fees (including counsel fees)*
Miscellaneous fees (other than underwriting discounts and commissions) that we anticipate we will incur in connection with the offering of securities under this registration statement on Form S-3. An estimate of the aggregate expenses*
Total* in connection with the issuance and distribution of the securities being offered will be included in the applicable prospectus supplement.
 __________________________________
* Estimated expenses are not presently known because they depend upon, among other things, the number of offerings that will be made pursuant to this registration statement, the amount and type of securities being offered and the timing of such offerings. The foregoing sets forth the general categories of expenses (other than underwriting discounts and commissions) that we anticipate we will incur in connection with the offering of securities under this registration statement on Form S-3. An estimate of the aggregate expenses in connection with the issuance and distribution of the securities being offered will be included in the applicable prospectus supplement.
Item 15Indemnification of Directors and Officers.

Sections 721 through 726 of the New York Business Corporation Law, or BCL, grant New York corporations broad powers to indemnify their present and former directors and officers and those of affiliated corporations against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with threatened, pending or completed actions, suits or proceedings to which they are parties or are threatened to be made parties by reason of being or having been such directors or officers, subject to specified conditions and exclusions; give a director or officer who successfully defends an action the right to be so indemnified; and permit a corporation to buy directors' and officers' liability insurance. Such indemnification is not exclusive of any other rights to which those indemnified may be entitled under any by-laws, agreement, vote of shareholders or otherwise.

Section 402(b) of the BCL permits a New York corporation to include in its certificate of incorporation a provision eliminating the potential monetary liability of a director to the corporation or its shareholders for breach of fiduciary duty as a director, provided that such provision may not eliminate the liability of a director (i) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (ii) for any transaction from which the director receives an improper personal benefit or (iii) for any acts in violation of Section 719 of the BCL. Section 719 provides that a director who votes or concurs in a corporate action will be liable to the corporation for the benefit of its creditors and shareholders for any damages suffered as a result of an action approving (i) an improper payment of a dividend, (ii) an improper redemption or purchase by the corporation of shares of the corporation, (iii) an improper distribution of assets to shareholders after dissolution of the corporation without adequately providing for all known liabilities of the corporation or (iv) the making of an improper loan to a director of the corporation.


The Registrant’s Restated Certificate of Incorporation includes the provisions permitted by Section 402(b).


The Registrant’s Restated Certificate of Incorporation also provides that we shall indemnify, to the fullest extent permitted by the BCL, each person (and the heirs, executors, or administrators of such person) who was or is a party or is threatened to be made a party to, or is involved in, any civil or criminal action, suit or proceeding, by reason of the fact that such person is or was a director or officer of our company or is or was serving at our request as a director or officer of another corporation, partnership, joint venture,



trust or other enterprise. We are also obligated to pay the cost of the expenses incurred by our officers and directors (including attorney’s fees) in defending themselves in such proceedings in advance of final disposition if the officer or director agrees to repay the amount

II-1

TABLE OF CONTENTS

advanced in the event it is ultimately determined that the officer or director was not entitled to be indemnified by us as authorized by our certificate of incorporation. We are not obligated to indemnify any director or officer (or his or her heirs, executors or administrators) in connection with a proceeding initiated by such person unless such proceeding was authorized or consented to by our Board of Directors. We have entered into indemnification agreements with each of our current directors to effectuate the indemnification provisions of our certificate of incorporation.


The Registrant’s by-laws also allow it to indemnify, in the same manner and under the same circumstances as set forth in Sections 721 through 726 of the BCL, any person who was or is a party or is threatened to be made a party to any action or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he is or was the Registrant’s representative, against expenses (including attorney’s fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with the action or proceeding if he acted in good faith and in a manner he reasonably believed to be in, or not opposed to, the Registrant’s best interests.


The Registrant also maintains an insurance policy insuring its directors and officers against liability for certain acts and omissions while acting in their official capacities on behalf of the Registrant.


Pursuant to the Registration Rights Agreement, we have agreed to indemnify in certain circumstances the selling shareholders against certain liabilities under the Securities Act. The selling shareholders have agreed to indemnify us in certain circumstances against certain liabilities, including certain liabilities under the Securities Act. The selling shareholders may indemnify any underwriter that participates in transactions involving the sale of shares of common stock against certain liabilities, including liabilities arising under the Securities Act, in accordance with the terms of any underwriting agreement that may be entered into in connection with such sale.

Item 16Exhibits.

The Exhibits listed on the Exhibit Index of this Registration Statement are filed herewith or are incorporated herein by reference to other filings.


filings.

Item 17Undertakings.

The undersigned registrant hereby undertakes:

(1)To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(iii)to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 (i)    to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)    to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in the volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and
(iii)    to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that paragraphs (i), (ii) and (iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

(2)That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.
(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
(4)That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:
(i)each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and


II-2

(2) That, for the purposes of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.

TABLE OF CONTENTS

(ii)each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
(5)That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
(i)any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii)any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;
(iii)the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and
(iv)any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
(6)The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
(7)If and when applicable, the undersigned registrant, hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act.
(8)Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.
(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(4) That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

II-3


(i)    each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement;

TABLE OF CONTENTS

EXHIBIT INDEX

Exhibit
Number
Description
1.1
Form of Underwriting or Distribution Agreement.*
4.1
Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement No. 33-80687 on Form S-1 dated December 21, 1995 (file no. 0-27618)).
Certificate of Amendment to the Certificate of Incorporation of Columbus McKinnon Corporation, dated as of May 18, 2009 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated May 18, 2009 (file no. 0-27618)).
Fourth Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated March 28, 2013, as filed with the Commission on March 28, 2013 (file no. 0-27618)).
4.4
Form of specimen common stock certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement No. 33-80687 on Form S-1 dated December 21, 1995).
4.5
Form of specimen preferred stock certificate.*
4.6
Certificate of Designations of Preferred Stock of Columbus McKinnon Corporation.*
Form of Senior Indenture.**
Form of Subordinated Indenture.**
4.9
Form of Senior Debt Security.*
4.10
Form of Subordinated Debt Security.*
4.11
Form of Warrant Agreement.*
4.12
Form of Warrant.*
4.13
Form of Rights Agent Agreement.*
4.14
Form of Rights Certificate.*
4.15
Form of Stock Purchase Contract.*
4.16
Form of Unit Agreement.*
Opinion of Hodgson Russ LLP**
Consent of Independent Registered Public Accounting Firm**
��
Consent of Hodgson Russ LLP (included in Exhibit 5.1).
Powers of Attorney (included on signature pages of this registration statement).
25.1
Statement of Eligibility of Trustee under the Senior Indenture on Form T-1*
25.2
Statement of Eligibility of Trustee under the Subordinated Indenture on Form T-1*

*To be filed, if necessary, by amendment hereto or pursuant to a Current Report on Form 8-K to be incorporated herein by reference.
**Filed herewith
(ii)    each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

(5)     That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

II-4


(i)    any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

TABLE OF CONTENTS


(ii)    any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

(iii)    the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

(iv)    any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

(6)     The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(7)     If and when applicable, the undersigned registrant, hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Act.



(8)     Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933, and will be governed by the final adjudication of such issue.




SIGNATURES


Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Amherst, State of New York, on April 24, 2017.


May 30, 2019.

COLUMBUS McKINNON CORPORATION

By:
/s/ Gregory P. Rustowicz
Gregory P. Rustowicz
Vice President and Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, Gregory P. Rustowicz and Alan S. Korman, or either of them, as his attorney in fact, to sign any amendments to this registration statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.





Signature
Title
Date
SignatureTitleDate
*
s/ Mark D. Morelli
President and Chief Executive Officer
and Director
(Principal Executive Officer)
April 24, 2017
May 30, 2019
Mark D. Morelli
/
s/ Gregory P. Rustowicz
Vice President and Chief Financial Officer
(Principal Financial Officer)
May 30, 2019
Gregory P. Rustowicz
s/ Richard H. Fleming
Chairman of the Board of Directors
May 30, 2019
Richard H. Fleming
s/ Ernest R. Verebelyi
Chairman Emeritus of the Board of Directors and Director
May 30, 2019
Ernest R. Verebelyi
s/ Liam G. McCarthy
Director
May 30, 2019
Liam G. McCarthy
s/ Heath A. Mitts
Director
May 30, 2019
Heath A. Mitts
s/ Nicholas T. Pinchuk
Director
May 30, 2019
Nicholas T. Pinchuk
s/ R. Scott Trumbull
Director
May 30, 2019
R. Scott Trumbull
s/ Kathryn V. Roedel
Director
May 30, 2019
Kathryn V. Roedel
s/ Aziz S. Aghili
Director
May 30, 2019
Aziz S. Aghili

II-5

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Amherst, State of New York, on May 30, 2019.

MAGNETEK, INC.
By:
/s/ Gregory P. Rustowicz
Gregory P. Rustowicz
Vice President

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, Gregory P. Rustowicz and Alan S. Korman, or either of them, as his attorney in fact, to sign any amendments to this registration statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature
Title
Date
s/ Mark D. Morelli
President and Director
(Principal Executive Officer)
May 30, 2019
Mark D. Morelli
s/ Gregory P. Rustowicz
Vice President, Treasurer and Director
(Principal Financial Officer and Principal Accounting Officer)
April 24, 2017
May 30, 2019
Gregory P. Rustowicz
s/ Alan S. Korman
Secretary and Director
May 30, 2019
*
Alan S. Korman

II-6

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Amherst, State of New York, on May 30, 2019.

UNIFIED INDUSTRIES, INC.
By:
/s/ Gregory P. Rustowicz
Gregory P. Rustowicz
Vice President

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, Gregory P. Rustowicz and Alan S. Korman, or either of them, as his attorney in fact, to sign any amendments to this registration statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature
Title
Date
s/ Mark D. Morelli
Chairman of the Board of Directors
(Principal Executive Officer)
April 24, 2017
May 30, 2019
Ernest R. Verebelyi
Mark D. Morelli
*
s/ Ed Butte
President
DirectorApril 24, 2017
May 30, 2019
Richard H. Fleming
Ed Butte
*
s/ Gregory P. Rustowicz
Vice President, Treasurer and Director
(Principal Financial Officer and Principal Accounting Officer)
DirectorApril 24, 2017
May 30, 2019
Linda A. Goodspeed
Gregory P. Rustowicz
*
s/ Alan S. Korman
Secretary and Director
DirectorApril 24, 2017
May 30, 2019
Liam G. McCarthy
Alan S. Korman

II-7

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Amherst, State of New York, on May 30, 2019.

YALE INDUSTRIAL PRODUCTS, INC.
*
By:
DirectorApril 24, 2017
/s/ Gregory P. Rustowicz
Heath A. Mitts
Gregory P. Rustowicz
*DirectorApril 24, 2017
Nicholas T. Pinchuk
*DirectorApril 24, 2017
Stephen Rabinowitz
*DirectorApril 24, 2017
R. Scott Trumbull
Vice President

*By: /s/

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints, Gregory P. Rustowicz

Gregory P. Rustowicz,
and Alan S. Korman, or either of them, as Attorney-in-Fact



EXHIBIT INDEX

his attorney in fact, to sign any amendments to this registration statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature
Title
Date
Exhibit
Numbers/ Mark D. Morelli
President and Director
(Principal Executive Officer)
Description
May 30, 2019
Mark D. Morelli
Form of Underwriting Agreement.*
s/ Gregory P. Rustowicz
Vice President, Treasurer and Director
(Principal Financial Officer and Principal Accounting Officer)
May 30, 2019
4.1Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Company’s Registration Statement No. 33-80687 on Form S-1 dated December 21, 1995 (file no. 0-27618)).
Gregory P. Rustowicz
4.2
s/ Alan S. Korman
Corporate Secretary and Director
Certificate of Amendment to the Certificate of Incorporation of Columbus McKinnon Corporation, dated as of
May 18, 2009 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated May 18, 2009 (file no. 0-27618)).30, 2019
4.3Fourth Amended and Restated Bylaws (incorporated herein by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K dated March 28, 2013, as filed with the Commission on March 28, 2013 (file no. 0-27618)).
4.4Form of specimen common stock certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement No. 33-80687 on Form S-1 dated December 21, 1995).
4.5Rights Agreement, dated as of May 18, 2009, between Columbus McKinnon Corporation and American Stock Transfer & Trust Company, LLC, which includes the form of Right Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Shares as Exhibit C (incorporated by reference to Exhibit 4.1 of Columbus McKinnon Corporation’s Current Report on Form 8-K dated May 19, 2009).
5.1Opinion of DLA Piper LLP (US).**
23.1Consent of Independent Registered Public Accounting Firm.***
23.2Consent of Independent Auditors.***
23.3Consent of DLA Piper LLP (US) (included in Exhibit 5.1).
Alan S. Korman


________________

II-8

* To be filed, if necessary, by amendment hereto or pursuant to a Current Report on Form 8-K to be incorporated herein by reference.
** Filed herewith.
***Previously filed.


21